ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1881

Deep Learning Approaches to Rheumatoid Arthritis Severity Prognosis

Zhong-Yuan Lai1, Aditya Varna Iyer2, Isaac Zachary To1, Ivano Lodato1, Simran Hiranandani1, Tommy LAM3, Ho So4 and Lai-Shan Tam5, 1Allos AI, London, United Kingdom, 2Allos AI, University of Oxford, Oxford, United Kingdom, 3Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong, 4Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 5The Chinese University of Hong Kong, New Territories, China

Meeting: ACR Convergence 2023

Keywords: Imaging, radiography, rheumatoid arthritis, Statistical methods, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1862–1894) Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis affecting a large sector of the global population. The disease is associated with a high socio-economic burden owing to disability caused and costs of treatment. Conventional diagnostic methods rely on the skill of trained clinicians in interpreting and prognosing the severity of RA from X-ray images. This is slow, costly, and often error prone. We propose novel AI models that can perform an automatic quantification of X-Ray damage.

Methods: Data is retrieved from the Prince of Wales Hospital in Hong Kong. Patients diagnosed with RA were recruited with physician’s diagnoses are recorded at the first clinic visit according to ICD9-CM. Inclusion criteria are 1) patients who carried the diagnosis code of RA (ICD9-CM: 714), 2) >= 1 follow up visit after disease onset, 3) serial XR hands available ( >= 1 set) after disease onset, 4) age >=18 at disease onset, and 5) DAS28 < 5.1. The final dataset consists of a cohort of ~600 X-ray images of hands and feet. Each X-ray image is labeled with a corresponding value for the van der Heijde Modified Sharp score (vdH score). Our trained deep learning model analyzes a typical X-ray image in two distinct ways:

1. Classification: we partition the dataset according to the vdH value into 11 disjoint sets. Each set corresponds to images with vdH score within a specific range. The classifier is then tasked with deciding the range of vdH values to be assigned to a typical X-ray image;

2. Regression: our trained model directly outputs a numerical value of the vdH score based on its analysis of a typical X-ray image. This task is computationally harder than classification as the model predicts continuous values and therefore can be used in disease progression analysis of X-rays collected over time.

These approaches are prefaced by preprocessing pipelines designed to take the intricacies of images into account. Our deep learning frameworks are based on the Visual Transformer (ViT) architecture. For regression, our framework can take prior information regarding RA severity into account, much in the same way that a physician performs annotation on an image. Prior information is integrated into the regression framework in the form of a trained shape model.

Results: We obtained accuracies between 70-75% on the validation dataset, for the 11-bin classification problem. We also computed the Area-Under-Curve score (AUC), which is a more accurate reflection on the robustness of our classification in the presence of imbalanced data. We obtained an AUC of 0.8. For the regression problem, we obtain relational errors of 0.25-0.3 (computed as fractional deviation of prediction from truths), competitive with a clinician.

Conclusion: We implement deep learning frameworks to automatically assign severity scores to X-rays of bones via classification or regression. With both frameworks we show that it is possible for deep learning prognostic pipelines to be robustly implemented and deployed for use in a conventional clinical workflow, thus paving the way for expedited prognosis and increased quality of care for RA patients.


Disclosures: Z. Lai: None; A. Iyer: None; I. To: None; I. Lodato: None; S. Hiranandani: None; T. LAM: None; H. So: None; L. Tam: AbbVie, 5, Amgen, 2, 5, Boehringer-Ingelheim, 2, 5, Eli Lilly, 2, GSK, 5, Janssen, 2, 5, Novartis, 5, Pfizer, 2, 5, Sanofi, 2.

To cite this abstract in AMA style:

Lai Z, Iyer A, To I, Lodato I, Hiranandani S, LAM T, So H, Tam L. Deep Learning Approaches to Rheumatoid Arthritis Severity Prognosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/deep-learning-approaches-to-rheumatoid-arthritis-severity-prognosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deep-learning-approaches-to-rheumatoid-arthritis-severity-prognosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology